In this article, we will look at the 11 Best Low Cost Stocks to Buy According to Analysts.
On September 13, Courtney Garcia, Payne Capital Management senior wealth advisor, appeared in an interview on CNBC to discuss the markets. Garcia emphasized diversification despite the strength of the tech sector. She supports owning tech stocks, especially as lower rates are expected to encourage investors to move money from cash equivalents into equities. However, Garcia advised investors to broaden exposure beyond tech to small caps, energy, and international markets.
She highlighted small caps as attractive due to their sensitivity to interest rates and potential benefits from less regulation and more merger and acquisition activity. She also stressed that small caps are under-owned relative to large caps, and this could offer good opportunities if the economy stays resilient.
Garcia also highlighted other sectors for diversification, including Energy and International stocks. These areas have not had the same strong run as tech and could provide additional growth opportunities as the market broadens. She emphasizes that there are many attractive places to deploy capital beyond just the top tech names.
With that, let’s take a look at the best low cost stocks to buy according to analysts.
Stocks chart
Our Methodology
For this article, we used Finviz Stock Screener, Seeking Alpha, and CNN as our sources. Using the screener, we aggregate a list of stocks trading below the forward P/E of 15, with analysts expecting more than 20% upside. Next, we cross-checked the P/E from Seeking Alpha and upside from CNN and ranked the stocks in ascending order of this metric. We have also added hedge fund sentiment around each stock sourced from Insider Monkey’s Q2 2025 database. Please note that the data was recorded on September 11, 2025.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
11 Best Low Cost Stocks to Buy According to Analysts
11. Ambev S.A (NYSE:ABEV)
Forward P/E Ratio: 12.71
Number of Hedge Fund Holders: 23
Analyst Upside Potential: 24.56%
Ambev S.A (NYSE:ABEV) is one of the Best Low Cost Stocks to Buy According to Analysts. Wall Street has a mixed opinion on Ambev S.A (NYSE:ABEV) after the company missed revenue estimates for its fiscal second quarter of 2025. The company delivered $3.59 billion in revenue, which grew around 2.65% year-over-year but fell short of expectations by $250.95 million. The EPS of $0.03 stayed in line with the consensus.
Management noted that its total organic volumes decreased by 4.5% year-over-year due to industry softness. This was mainly due to the colder temperatures, which negatively affected key consumption occasions, particularly in the South and Southeast regions, which account for nearly 60% of the industry demand.
Wall Street has had a mixed opinion on Ambev S.A (NYSE:ABEV) since its earnings release. On August 1, Evercore ISI reiterated a Buy rating on the stock with a price target of $4. However, more recently, on August 20, UBS reiterated a Hold rating on the stock, while reducing the price target from $2.5 to $2.2.
Ambev S.A (NYSE:ABEV) is a Brazil-based company that brews, distributes, and sells beer, soft drinks, and other beverages across the Americas.
10. ONEOK, Inc. (NYSE:OKE)
Forward P/E Ratio: 13.53
Number of Hedge Fund Holders: 44
Analyst Upside Potential: 26.79%
ONEOK, Inc. (NYSE:OKE) is one of the Best Low Cost Stocks to Buy According to Analysts. On August 25, ONEOK, Inc. (NYSE:OKE), along with WhiteWater, MPLX, and Enbridge, announced a new natural gas pipeline called the Eiger Express.
The pipeline is expected to transport gas from the Permian Basin in West Texas to the Houston area and Corpus Christi markets in Texas. It is about 450 miles long and 42 inches in diameter, and can carry up to 2.5 billion cubic feet of natural gas per day.
Management noted that the pipeline will source gas from processing plants operated by ONEOK and MPLX, connecting the Midland and Delaware basins. The joint venture for this project is owned 70% by the Matterhorn joint venture, 15% by ONEOK, Inc. (NYSE:OKE), and 15% by MPLX, with ONEOK’s total stake being 25.5%. Moreover, WhiteWater will build and operate the pipeline.
ONEOK, Inc. (NYSE:OKE) is a midstream energy company that provides services including gathering, processing, transportation, storage, and export of natural gas and liquids.
9. Diamondback Energy, Inc. (NASDAQ:FANG)
Forward P/E Ratio: 10.85
Number of Hedge Fund Holders: 46
Analyst Upside Potential: 28.90%
Diamondback Energy, Inc. (NASDAQ:FANG) is one of the Best Low Cost Stocks to Buy According to Analysts. On September 2, the company announced that Deep Blue will acquire Environmental Disposal Systems, LLC from Diamondback in a deal valued at $750 million.
The acquisition is expected to nearly double Deep Blue’s size, and as part of the agreement, Diamondback Energy, Inc. (NASDAQ:FANG) renewed a 15-year agreement for produced and supplied water within a 12-county area in the Midland Basin. Diamondback will keep a 30% ownership stake in Deep Blue and will receive about $675 million upfront, plus up to $200 million more through performance-based earnouts until 2028.
Moreover, after the acquisition, Deep Blue’s system will handle 1.2 million barrels per day of treatment, 1.6 million barrels per day gathered, 3.4 million barrels per day disposal capacity, plus extensive pipeline infrastructure and dedicated acreage.
Diamondback Energy, Inc. (NASDAQ:FANG) is an independent oil and natural gas company focused on exploring and developing unconventional reserves in the Permian Basin, Texas.
8. Sanofi (NASDAQ:SNY)
Forward P/E Ratio: 10.22
Number of Hedge Fund Holders: 24
Analyst Upside Potential: 30.65%
Sanofi (NASDAQ:SNY) is one of the Best Low Cost Stocks to Buy According to Analysts. On September 6, Leerink Partners analyst David Risinger maintained a Buy rating on Sanofi (NASDAQ:SNY) without a price target.
The analyst acknowledged the challenges faced by the company with Amlitelimab in its Phase 3 trial, as the results did not meet the high benchmark set by Dupixent. However, Risinger noted that Amlitelimab can still achieve its primary and secondary endpoints, showing promise as a second-line treatment for atopic dermatitis.
The analyst highlighted the drug’s novel mechanism and the convenience of quarterly dosing, which could help it stand out in the competitive market. Moreover, the safety profile of the drug is also encouraging, with a low rate of adverse events. Risinger remains optimistic for the ongoing and upcoming trials and believes that positive data will strengthen the drug’s position over time.
Sanofi (NASDAQ:SNY) is a France-based healthcare company that researches, develops, manufactures, and markets therapeutic solutions.
7. Fiserv, Inc. (NYSE:FI)
Forward P/E Ratio: 12.98
Number of Hedge Fund Holders: 94
Analyst Upside Potential: 36.22%
Fiserv, Inc. (NYSE:FI) is one of the Best Low Cost Stocks to Buy According to Analysts. On September 4, Fiserv, Inc. (NYSE:FI) announced the acquisition of CardFree, a platform offering order, payment, and loyalty solutions for merchants.
Management noted that this acquisition is aimed at enhancing Clover’s point-of-sale system, which is widely regarded as one of the smartest in the market. CardFree’s technology will be fully integrated into both Clover and Commerce Hub ecosystems. This integration is expected to bring new capabilities, including drive-through software, kiosk functionalities, sub-inventory management, and support for third-party software like loyalty programs and delivery services.
Fiserv, Inc. (NYSE:FI) believes that combining CardFree’s seamless mobile ordering and payment platform with Clover will boost scalability and flexibility. This will empower hospitality, restaurant, and lodging businesses to streamline operations while improving customer experiences. Financial terms of the deal were not disclosed.
Fiserv, Inc. (NYSE:FI) is a global company that provides payments and financial technology solutions. It serves businesses of all sizes with products like payment processing, point-of-sale systems, and fraud protection.
6. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Forward P/E Ratio: 14.12
Number of Hedge Fund Holders: 73
Analyst Upside Potential: 36.91%
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the Best Low Cost Stocks to Buy According to Analysts. On September 8, Evan Seigerman from BMO Capital maintained a Buy rating on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) with a price target of $640.
The analyst noted that his rating is based on the strong results from Phase 3 trials for the company’s cat and birch allergy antibody cocktails. The results showed significant symptom reduction with key improvements seen in ocular itch, redness, and skin reaction, especially for cat allergy patients sensitized to FelD1.
Seigerman notes the clinical data address a large unmet medical need. However, he also points out uncertainty about commercial uptake due to generic antihistamines dominating allergy treatment. Despite this, he remains positive on Regeneron Pharmaceuticals, Inc.’s (NASDAQ:REGN overall outlook.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is a biotechnology company that develops, manufactures, and sells medicines for serious diseases.
5. PG&E Corporation (NYSE:PCG)
Forward P/E Ratio: 10.18
Number of Hedge Fund Holders: 77
Analyst Upside Potential: 37.61%
PG&E Corporation (NYSE:PCG) is one of the Best Low Cost Stocks to Buy According to Analysts. On September 2, Jefferies analyst Julien Dumoulin-Smith maintained a Buy rating on PG&E Corporation (NYSE:PCG) while raising the price target from $19 to $22.
The analyst noted the leaked wildfire bill was added to SB254, which was a securitization bill and was paused at third reading in the Assembly. He noted that the arrival of this bill strengthens investor confidence for companies like PG&E Corporation (NYSE:PCG) as the wildfire season approaches. Moreover, the wildfire fund bill remains mostly the same as the leaked version, which reduces concerns about increased shareholder funding. As a result, Jefferies remains a Buy on the stock.
In addition to Jefferies, on September 8, Ryan Levine from Citi also reiterated a Buy rating on PG&E Corporation (NYSE:PCG) with a price target of $21.
PG&E Corporation (NYSE:PCG) is a holding company whose main operating business is Pacific Gas and Electric Company. The company provides electricity and natural gas to customers in Northern and Central California.
4. Expand Energy Corporation (NASDAQ:EXE)
Forward P/E Ratio: 14.28
Number of Hedge Fund Holders: 93
Analyst Upside Potential: 39.94%
Expand Energy Corporation (NASDAQ:EXE) is one of the Best Low Cost Stocks to Buy According to Analysts. On September 11, John Freeman from Raymond James raised the firm’s price target on Expand Energy Corporation (NASDAQ:EXE) from $146 to $150, while keeping a Buy rating on the stock.
The analyst noted that his Q3 production estimates remain steady for the company as he is expecting little change from the previous quarter. He noted that the company is well-positioned for growth. Moreover, the company is set to benefit from the rising natural gas prices, and its production is also expected to grow over the next few years.
In addition, on September 10, Mark Lear from Piper Sandler also reiterated a Buy rating on the stock with a price target of $136. Overall, analysts’ 12-month price target reflects 39.94% upside from the current level.
Expand Energy Corporation (NASDAQ:EXE) is an independent natural gas producer in the United States. It operates mainly in Louisiana, Pennsylvania, West Virginia, and Ohio, focusing on natural gas, oil, and natural gas liquids.
3. Keurig Dr Pepper Inc. (NASDAQ:KDP)
Forward P/E Ratio: 13.4
Number of Hedge Fund Holders: 46
Analyst Upside Potential: 40.31%
Keurig Dr Pepper Inc. (NASDAQ:KDP) is one of the Best Low Cost Stocks to Buy According to Analysts. On August 28, Keurig Dr Pepper Inc. (NASDAQ:KDP) announced a new strategic partnership with Disney Advertising. The partnership aims to create personalized consumer experiences by combining fandom, media, and shopper insights.
Management noted that the partnership includes innovative brand activations, such as sponsored content in major sports programs, augmented reality in-game features, and precision marketing driven by retail data. Moreover, one key element is Keurig Dr Pepper Inc.’s (NASDAQ:KDP) Fansville series, which will now be integrated into live college football broadcasts using mixed reality, creating an immersive viewing experience.
The partnership builds on years of co-innovation and the company’s effort to keep its presence in college football. Moreover, management noted that it will use combined data from retail and fan behavior to deliver more targeted and effective marketing.
Keurig Dr Pepper Inc. (NASDAQ:KDP) is a leading North American beverage company that manufactures, markets, and distributes a wide range of beverages.
2. Novo Nordisk A/S (NYSE:NVO)
Forward P/E Ratio: 14.2
Number of Hedge Fund Holders: 45
Analyst Upside Potential: 43.15%
Novo Nordisk A/S (NYSE:NVO) is one of the Best Low Cost Stocks to Buy According to Analysts. On September 10, Novo Nordisk A/S (NYSE:NVO) announced a major company-wide transformation with the goal of simplifying the organization, speeding up decision-making, and focusing resources on growth in diabetes and obesity.
As part of this strategy, the company will reduce its workforce by around 9,000 positions out of 78,400, cutting around 5,000 jobs in Denmark. Management noted that this move is to address the challenges that have arisen due to rapid growth, and has brought complexity and higher costs. Now the company faces a more competitive and consumer-driven obesity market with slower growth recently.
Savings from cutting the jobs are estimated at DKK 8 billion annually by the end of 2026. Management believes that this will support growth initiatives in diabetes and obesity. The one-time restructuring cost is estimated at around DKK 8 billion in 2025; as a result, the operating profit growth outlook is now expected between 4% to 10% against the previous expectation of 10% to 16%.
Novo Nordisk A/S (NYSE:NVO) is a global healthcare company focused mainly on diabetes and obesity care.
1. Charter Communications, Inc. (NASDAQ:CHTR)
Forward P/E Ratio: 7.13
Number of Hedge Fund Holders: 56
Analyst Upside Potential: 59.70%
Charter Communications, Inc. (NASDAQ:CHTR) is one of the Best Low Cost Stocks to Buy According to Analysts. On September 4, Charter Communications, Inc. (NASDAQ:CHTR) announced extending its long-term partnership with CSG till September 30, 2031.
As a result of this extension, the company will continue to use CSG’s cloud-native SaaS platform called CSG Ascendon. The platform allows Charter Communications, Inc. (NASDAQ:CHTR) to offer a seamless entertainment experience as it combines live TV access with streaming apps.
Moreover, CSG will also keep supporting the company’s residential Internet, TV, and home phone customers. Management noted that the CSG Ascendon combines revenue and customer experience management with AI-driven analytics, thereby making it a strong tool to create new digital offerings and unlock new revenue streams.
Charter Communications, Inc. (NASDAQ:CHTR) is a major broadband connectivity company operating in 41 states under the Spectrum brand. It provides residential and business services, including high-speed internet, cable TV, mobile, and voice solutions.
While we acknowledge the potential of CHTR to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than CHTR and that has 100x upside potential, check out our report about this cheapest AI stock.
READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
